Team
health

Opioid Conversion Calculator

When pain management requires switching opioids or changing the route of administration, precise dosing is essential to maintain therapeutic effect without increasing toxicity. Opioid conversion uses equianalgesic dosing principles — standardized potency ratios derived from clinical research — to translate a dose of one drug into an equivalent dose of another. Clinicians and pharmacists rely on these conversions daily in hospital care, palliative medicine, and chronic pain management.

Last updated:

Creators Adena Benn, BSc
7,726 people find this calculator helpful

Understanding Equianalgesic Dosing

Equianalgesic dosing compares the pain-relieving power of different opioids relative to a standard reference — typically 10 mg of intravenous morphine. Each opioid has a defined potency ratio that accounts for differences in receptor binding affinity, bioavailability, and duration of action.

The route of administration dramatically affects how much drug reaches the systemic circulation. Oral morphine, for example, undergoes significant first-pass hepatic metabolism, requiring roughly three times the intravenous dose to produce the same analgesic effect. Subcutaneous and transdermal routes bypass the gastrointestinal tract, changing absorption rates and peak concentrations.

Published equianalgesic charts compile decades of clinical observation and pharmacokinetic studies. They serve as a foundation for safe opioid switching, though individual patient variation — due to age, organ function, genetic polymorphisms in drug-metabolizing enzymes, and concurrent medications — means clinicians must use these values as a starting point, not a fixed rule.

Opioid Conversion Formula

All conversions in this calculator reference intravenous morphine as the baseline. The general formula adjusts for both the target drug's potency and the route of administration:

Target Dose = IV Morphine Dose × Potency Factor × (1 − Cross-tolerance)

Where:

Potency Factor = relative strength compared to IV morphine

Cross-tolerance = fraction of tolerance that transfers between opioids (0–1 scale)

  • IV Morphine Dose — The current total daily or single dose administered intravenously, in milligrams
  • Potency Factor — The ratio of the target opioid's strength to intravenous morphine (e.g., oral morphine is 1/3, fentanyl SC is 0.02)
  • Cross-tolerance — The proportion of tolerance that carries over from the previous opioid (25–50% is typical; enter as decimal 0.25–0.50)

Route-Specific Conversion Ratios

Different opioids exhibit markedly different potencies. Fentanyl, for instance, is roughly 50–100 times stronger than morphine — a small dosing error can be catastrophic. Codeine and tramadol, by contrast, are weaker than morphine and require much larger doses.

Bioavailability also varies by route:

  • Intravenous: 100% bioavailability; used as the reference standard.
  • Oral: 20–30% bioavailability for morphine due to first-pass metabolism; requires 3× the IV dose.
  • Subcutaneous: 66–75% bioavailability; requires 1.5× the IV dose for morphine.
  • Transdermal: Provides steady-state delivery over days; suitable for opioid-tolerant patients only.

Rectal administration (diamorphine, morphine) approximates subcutaneous bioavailability. The choice of route depends on patient ability to swallow, renal and hepatic function, and clinical scenario.

Key Safety Considerations

Opioid conversion errors can rapidly lead to overdose or inadequate analgesia. Observe these critical precautions:

  1. Always Account for Incomplete Cross-Tolerance — When switching from one opioid to another, tolerance to the new drug is incomplete. A 25–50% dose reduction is standard practice, even when equianalgesic math suggests a 1:1 swap. Starting low and titrating upward over 24–48 hours is safer than aggressive dosing.
  2. Check Cumulative Daily Opioid Load — Patients often receive multiple opioid formulations simultaneously (long-acting plus short-acting). Sum all daily opioid doses and convert the total to morphine equivalents before calculating the new regimen. Missing a concurrent dose can lead to dangerous underdosing.
  3. Verify Renal and Hepatic Function — Morphine, codeine, and tramadol rely heavily on renal clearance; fentanyl and buprenorphine are hepatically metabolized. Impaired organ function reduces clearance and increases risk of accumulation and toxicity. Dosing adjustments beyond equianalgesic conversion may be necessary.
  4. Monitor for Signs of Over- or Under-Dosing — Respiratory depression, altered mental status, and pinpoint pupils signal opioid excess. Inadequate analgesia, anxiety, and diaphoresis suggest underdosing. Reassess at 24 hours post-conversion and adjust incrementally rather than making large changes at once.

Clinical Context and Special Populations

Opioid tolerance develops through chronic exposure, reducing analgesic and euphoric effects. Cross-tolerance — where tolerance to one opioid carries partially to others — complicates switching. A patient maintained on high-dose oxycodone for months will retain some tolerance when switched to morphine, necessitating lower-than-equianalgesic doses initially.

Older adults metabolize opioids more slowly and are more sensitive to central nervous system effects; many guidelines recommend starting 25–50% below standard equianalgesic doses. Patients with severe renal impairment may accumulate morphine's active metabolites (morphine-3-glucuronide and morphine-6-glucuronide), which can cause delirium and respiratory depression over days.

Transdermal fentanyl and buprenorphine patches require careful selection: they suit only opioid-tolerant patients and take 12–24 hours (fentanyl) or 12–72 hours (buprenorphine) to reach steady state. Starting them in opioid-naive patients or using them for acute pain is unsafe.

Frequently Asked Questions

Why do I need a higher oral dose than an IV dose of morphine?

Oral morphine is absorbed from the gastrointestinal tract and immediately metabolized by the liver (first-pass metabolism) before reaching systemic circulation. Roughly 70–80% of the dose is inactivated before it takes effect, so you must give three times as much orally to match the pain relief from an IV dose. Intravenous administration bypasses this loss, delivering 100% of the dose to the bloodstream.

What does cross-tolerance mean, and why should I reduce the dose when switching opioids?

Cross-tolerance is the phenomenon where chronic use of one opioid causes reduced sensitivity to other opioids in the same drug class. When you switch medications, the patient's nervous system is already partially desensitized to opioids generally. Although equianalgesic charts suggest equivalent doses, in practice the new opioid is more effective in a tolerant patient — so you reduce the dose by 25–50% initially to avoid overdose. You can then gradually increase it if pain control is inadequate.

Is fentanyl really 100 times stronger than morphine?

Fentanyl is roughly 50–100 times more potent on a milligram-for-milligram basis, depending on the route. A 100 microgram fentanyl patch, for example, delivers approximately 2–4 mg of morphine equivalent per day. This extreme potency is why fentanyl dosing errors are catastrophic — a transdermal patch containing just 25 micrograms is enough to cause fatal respiratory depression in an opioid-naive person. Always verify fentanyl doses independently and avoid common calculation mistakes.

Can I convert from transdermal fentanyl patch directly to oral morphine?

Yes, but with caution. The conversion requires two steps: first, calculate the 24-hour fentanyl release from the patch (a 25 mcg/hr patch delivers about 600 mcg over 24 hours); second, multiply by the fentanyl-to-morphine ratio (approximately 1 mcg fentanyl = 2–3 mg morphine). Always start with the lower estimate, and account for cross-tolerance by reducing the calculated dose by 25–50%. Because patches reach steady state slowly, overlap the old patch with the new opioid for at least 12 hours.

How do I adjust opioid doses for elderly patients?

Older adults have reduced hepatic metabolism, decreased renal clearance, increased central nervous system sensitivity, and higher rates of drug interactions. Start with 25–50% of the standard equianalgesic dose and titrate slowly (every 2–3 days rather than daily). Monitor carefully for delirium, constipation, respiratory depression, and falls. Renal function should be formally assessed; if creatinine clearance is below 60 mL/min, avoid morphine-based regimens and prefer fentanyl or buprenorphine.

What is the safest way to use this calculator in clinical practice?

Use the calculator as a reference only, not a substitute for clinical judgment. Cross-check the result against published equianalgesic charts and dose your patient conservatively. Document the reason for the conversion (inadequate analgesia, intolerable side effects, or route change) and the cross-tolerance adjustment you applied. Reassess at 24 hours, looking for signs of over- or under-dosing. Involve a pharmacist when possible — medication error detection by a second clinician significantly reduces harm.

More health calculators (see all)

Infant Tylenol Dosage Calculator Gestational Age Calculator Amoxicillin Pediatric Dosage Calculator BED Calculator Allowable Blood Loss Calculator BAC Calculator Vaccine Queue Calculator for India LV Mass Index Calculator